Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2015 August;63(4) > Minerva Cardioangiologica 2015 August;63(4):297-315



A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


Minerva Cardioangiologica 2015 August;63(4):297-315


Novel bioresorbable scaffolds technologies: current status and future directions

Stanetic B. M. 1, Iqbal J. 2, Onuma Y. 3, Serruys P. W. 4

1 Department of Cardiology, University Hospital Clinical Centre Banja Luka, Banja Luka, Bosnia and Herzegovina;
2 Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK;
3 Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands;
4 International Centre of Circulatory Health, Imperial College London, London, UK

Over the past century, coronary artery disease (CAD) has remained a leading cause of death worldwide, managed with enormous progress by medicine, from the development of advanced drugs to highly sophisticated revascularization modalities. Among them, as confirmed by recent studies, bioresorbable scaffolds (BRSs) have shown to have the potential to overtake conventional stents. This review presents their material composition and properties, those currently used in clinical evaluation, and their current limitations and potential improvements.

language: English


top of page